Titan Pharmaceuticals, Inc. Selling, General and Administrative Expense
Titan Pharmaceuticals, Inc. reported Selling, General and Administrative Expense of $979.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2021-11-15
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2021-09-30 was $979.00K, a 26.22% decline year-over-year.
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2021-06-30 was $1.03M, a 15.37% decline year-over-year.
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2020-09-30 was $1.33M, a 56.10% decline year-over-year.
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2020-06-30 was $1.22M, a 62.15% decline year-over-year.
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2019 was $11.93M, a 73.68% increase from fiscal 2018.
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2018 was $6.87M, a 35.45% increase from fiscal 2017.
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2017 was $5.07M, a 10.29% increase from fiscal 2016.
- Titan Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2016 was $4.60M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | $979.00K 10-Q · filed 2021-11-15 | $2.01M derived: sum of 2 quarters · filed 2021-11-15 | $3.34M 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $1.03M 10-Q · filed 2021-08-16 | $2.36M 10-Q · filed 2021-08-16 | |||||
| 2020-09-30 | $1.33M 10-Q · filed 2021-11-15 | $3.55M 10-Q · filed 2020-11-16 | $2.55M derived: sum of 2 quarters · filed 2021-11-15 | $4.05M 10-Q · filed 2021-11-15 | $10.14M 10-Q · filed 2020-11-16 | $8.25M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.22M 10-Q · filed 2021-08-16 | $3.47M 10-Q · filed 2020-08-14 | $2.51M 10-Q · filed 2021-08-16 | $6.59M 10-Q · filed 2020-08-14 | $6.93M derived: sum of 3 quarters · filed 2021-08-16 | $9.95M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $3.11M 10-Q · filed 2020-05-15 | $5.70M derived: sum of 2 quarters · filed 2020-05-15 | $8.73M derived: sum of 3 quarters · filed 2020-11-16 | $11.96M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $5.61M derived: sum of 2 quarters · filed 2020-11-16 | $8.84M derived: sum of 3 quarters · filed 2020-11-16 | $11.93M 10-K · filed 2020-03-30 | |||
| 2019-09-30 | $3.02M 10-Q · filed 2020-11-16 | $6.25M derived: sum of 2 quarters · filed 2020-11-16 | $9.34M 10-Q · filed 2020-11-16 | $11.69M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $3.23M 10-Q · filed 2020-08-14 | $6.31M 10-Q · filed 2020-08-14 | $8.67M derived: sum of 3 quarters · filed 2020-08-14 | $10.19M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $3.08M 10-Q · filed 2020-05-15 | $5.44M derived: sum of 2 quarters · filed 2020-05-15 | $6.95M derived: sum of 3 quarters · filed 2020-05-15 | $8.33M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $3.87M derived: sum of 2 quarters · filed 2020-03-30 | $5.25M derived: sum of 3 quarters · filed 2020-03-30 | $6.87M 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $1.51M 10-Q · filed 2019-11-14 | $2.89M derived: sum of 2 quarters · filed 2019-11-14 | $4.51M 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $1.38M 10-Q · filed 2019-08-14 | $3.00M 10-Q · filed 2019-08-14 | |||||
| 2018-03-31 | $1.61M 10-Q · filed 2019-05-15 | ||||||
| 2017-12-31 | $5.07M 10-K/A · filed 2019-04-02 | ||||||
| 2016-12-31 | $4.60M 10-K/A · filed 2019-04-02 |